China
· Delayed Price · Currency is CNY Shanghai Pharmaceuticals Holding Statistics
Total Valuation
Shanghai Pharmaceuticals Holding has a market cap or net worth of CNY 69.28 billion. The enterprise value is 95.44 billion.
| Market Cap | 69.28B |
| Enterprise Value | 95.44B |
Important Dates
The last earnings date was Monday, October 28, 2024.
| Earnings Date | Oct 28, 2024 |
| Ex-Dividend Date | Sep 24, 2024 |
Share Statistics
Shanghai Pharmaceuticals Holding has 3.70 billion shares outstanding. The number of shares has decreased by -0.83% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 3.70B |
| Shares Change (YoY) | -0.83% |
| Shares Change (QoQ) | +0.46% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 14.37% |
| Float | 1.83B |
Valuation Ratios
The trailing PE ratio is 19.36 and the forward PE ratio is 15.39. Shanghai Pharmaceuticals Holding's PEG ratio is 1.04.
| PE Ratio | 19.36 |
| Forward PE | 15.39 |
| PS Ratio | 0.29 |
| PB Ratio | 1.09 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 24.28 |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.04 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.26, with an EV/FCF ratio of 29.91.
| EV / Earnings | 23.71 |
| EV / Sales | 0.35 |
| EV / EBITDA | 9.26 |
| EV / EBIT | 11.34 |
| EV / FCF | 29.91 |
Financial Position
The company has a current ratio of 1.34, with a Debt / Equity ratio of 0.68.
| Current Ratio | 1.34 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.68 |
| Debt / EBITDA | 5.46 |
| Debt / FCF | 17.63 |
| Interest Coverage | 4.65 |
Financial Efficiency
Return on equity (ROE) is 6.41% and return on invested capital (ROIC) is 3.86%.
| Return on Equity (ROE) | 6.41% |
| Return on Assets (ROA) | 2.41% |
| Return on Capital (ROIC) | 3.86% |
| Revenue Per Employee | 5.66M |
| Profits Per Employee | 83,577 |
| Employee Count | 48,164 |
| Asset Turnover | 1.25 |
| Inventory Turnover | 6.67 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.22% in the last 52 weeks. The beta is 0.30, so Shanghai Pharmaceuticals Holding's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | +16.22% |
| 50-Day Moving Average | 19.79 |
| 200-Day Moving Average | 18.59 |
| Relative Strength Index (RSI) | 58.82 |
| Average Volume (20 Days) | 26,385,017 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Shanghai Pharmaceuticals Holding had revenue of CNY 272.42 billion and earned 4.03 billion in profits. Earnings per share was 1.08.
| Revenue | 272.42B |
| Gross Profit | 30.14B |
| Operating Income | 8.42B |
| Pretax Income | 7.18B |
| Net Income | 4.03B |
| EBITDA | 9.62B |
| EBIT | 8.42B |
| Earnings Per Share (EPS) | 1.08 |
Balance Sheet
The company has 42.39 billion in cash and 56.25 billion in debt, giving a net cash position of -13.87 billion or -3.74 per share.
| Cash & Cash Equivalents | 42.39B |
| Total Debt | 56.25B |
| Net Cash | -13.87B |
| Net Cash Per Share | -3.74 |
| Equity (Book Value) | 83.16B |
| Book Value Per Share | 19.13 |
| Working Capital | 44.26B |
Cash Flow
In the last 12 months, operating cash flow was 5.71 billion and capital expenditures -2.52 billion, giving a free cash flow of 3.19 billion.
| Operating Cash Flow | 5.71B |
| Capital Expenditures | -2.52B |
| Free Cash Flow | 3.19B |
| FCF Per Share | 0.86 |
Margins
Gross margin is 11.07%, with operating and profit margins of 3.09% and 1.48%.
| Gross Margin | 11.07% |
| Operating Margin | 3.09% |
| Pretax Margin | 2.64% |
| Profit Margin | 1.48% |
| EBITDA Margin | 3.53% |
| EBIT Margin | 3.09% |
| FCF Margin | 1.17% |
Dividends & Yields
This stock pays an annual dividend of 0.41, which amounts to a dividend yield of 1.94%.
| Dividend Per Share | 0.41 |
| Dividend Yield | 1.94% |
| Dividend Growth (YoY) | -19.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 85.84% |
| Buyback Yield | 0.83% |
| Shareholder Yield | 2.77% |
| Earnings Yield | 5.17% |
| FCF Yield | 4.12% |
Stock Splits
The last stock split was on August 16, 2007. It was a forward split with a ratio of 1.2.
| Last Split Date | Aug 16, 2007 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Shanghai Pharmaceuticals Holding has an Altman Z-Score of 2.08. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.08 |
| Piotroski F-Score | n/a |